HUMAN FETAL TISSUE – Adds to existing law to establish provisions regarding the use of human fetal tissue in products.

Idaho's S 1310 requires explicit labeling on products (including vaccines and medical products) developed using human fetal tissue in their testing or production. Manufacturers must label such products, while retailers are only liable if they knew about the labeling requirement and failed to display it. Violations could trigger civil penalties up to $5,000 per violation or 5% of the product's sales revenue in Idaho. The law applies to any product where fetal tissue was used in development, testing, or production, and takes effect July 1, 2026.